Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Synthetic polyamine analogues as antineoplastics.

R J Bergeron1, A H Neims, J S McManis

  • 1Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville 32610.

Journal of Medicinal Chemistry
|June 1, 1988
PubMed
Summary

New N-alkylated spermine compounds, including diethylspermine (DESPM-3), show potent antiproliferative activity against leukemia cells. DESPM-3 demonstrated significant tumor reduction and increased lifespan in mice, suggesting therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AATF mediates an antiapoptotic effect of the unfolded protein response through transcriptional regulation of AKT1.

Cell death and differentiation·2009
Same author

Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex.

Clinical and experimental immunology·2009
Same author

Control of irritable bowel syndrome with polyamine analogs: a structure-activity study.

Digestive diseases and sciences·2002
Same author

An atypical population of NK cells that spontaneously secrete IFN-gamma and IL-4 is present in the intraepithelial lymphoid compartment of the rat.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Nicotinamide adenine dinucleotide (NAD) and its metabolites inhibit T lymphocyte proliferation: role of cell surface NAD glycohydrolase and pyrophosphatase activities.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same author

Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferatives.

Journal of medicinal chemistry·2001

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Spermine is a polyamine crucial for cell growth and proliferation.
  • Modifications of spermine, such as N-alkylation, can alter its biological activity.
  • Investigating novel spermine derivatives for anticancer properties is an active area of research.

Purpose of the Study:

  • To synthesize and evaluate the antiproliferative activity of N-alkylated spermine compounds.
  • To establish structure-activity relationships for these novel compounds.
  • To assess the in vivo efficacy of the most promising compound against leukemia.

Main Methods:

  • Synthesis of N-alkylated spermine analogs, including N1,N12-dimethylspermine (DMSPM-2), N1,N12-diethylspermine (DESPM-3), and N1,N12-dipropylspermine (DPSPM-4).

Related Experiment Videos

  • In vitro antiproliferative assays using L1210, Daudi, and HL-60 cell lines.
  • Cell cycle analysis via flow cytometry and assessment of mitochondrial DNA content.
  • In vivo studies using a murine leukemia model (L1210) in DBA/2 mice.

    • Main Results:

    • DMSPM-2, DESPM-3, and DPSPM-4 inhibited L1210 cell growth with IC50 values < 1 microM.
    • DESPM-3 exhibited similar activity against Daudi and HL-60 cells.
    • DESPM-3 treatment led to decreased cell size, mitochondrial DNA, and arrested cell growth.
    • In vivo treatment with DESPM-3 increased lifespan by over 200% in mice with L1210 leukemia, with some long-term survivors appearing tumor-free.

    Conclusions:

    • N-alkylation of spermine can yield potent antiproliferative agents.
    • DESPM-3 shows significant promise as an anticancer therapeutic, demonstrating both in vitro and in vivo efficacy.
    • Further investigation into DESPM-3's mechanism of action and therapeutic potential is warranted.